Hello guys, Welcome to Africa's Largest Video Search Engine, and you are watching Be vigilant: management of checkpoint inibitor toxicities. and this video is uploaded by VJOncology at 2016-12-07T04:57:45-08:00. We are just promoting this video only for entertainment and educational purpose only. I hop you like our Video Search Engine. [Tba05Z8qs6c]
| Name | Be vigilant: management of checkpoint inibitor toxicities |
| Video Uploader | Video From VJOncology |
| Upload Date | This Video Uploaded At 07-12-2016 12:57:45 |
| Video Discription | Bernardo Rapoport, MD and Ronwyn Van Eeden MBChB, FCP(SA) of The Medical Oncology Centre of Rosebank, Johannesburg, South Africa discuss how to manage immune-related toxicities associated with checkpoint inhibitors. Skin toxicity is a common side effect, which can be quite debilitating and affecting patients’ quality of life. Colitis symptoms can be very severe and should be treated promptly with corticosteroids or infliximab to avoid morbidity and mortality. Recorded at the Multinational Association of Supportive Care in Cancer (MASCC) and International Society of Ocular Oncology (ISOO) 2016 Annual Meeting on Supportive Care in Cancer held in Adelaide, Australia. [Tba05Z8qs6c] |
| Category | Education |
| Tags | toxicities | checkpoint inhibitors | skin toxicity | side effect | quality of life | colitis | corticosteroids | infliximab | morbidity | mortality | MASCC 2016 | Bernardo Rapoport | Field: Supportive Care |
